PNC-27

PNC-27 is a synthetic research peptide derived from a segment of the p53 tumor-suppressor protein and linked to a membrane-active peptide sequence. It has been investigated primarily in laboratory and preclinical research examining interactions with HDM-2 (also known as MDM2) and mechanisms associated with cancer-cell membrane biology.

Research involving PNC-27 examines p53/MDM2-associated interactions, membrane disruption mechanisms, cancer-cell biology, cellular viability, and peptide-target interactions in experimental models.

Research Classification: p53-derived experimental research peptide Form: Lyophilized peptide Intended Use: Laboratory research

Research Use Only. Not for human or veterinary use. PNC-27 is an experimental research compound and is not an approved cancer treatment or therapeutic drug. This product is intended solely for qualified laboratory research and analytical applications.